FZMD Stock Overview
Fuse Medical, Inc. manufactures and distributes medical devices in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Fuse Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.095 |
| 52 Week High | US$0.25 |
| 52 Week Low | US$0.051 |
| Beta | -0.38 |
| 1 Month Change | -11.63% |
| 3 Month Change | 5.32% |
| 1 Year Change | n/a |
| 3 Year Change | -45.68% |
| 5 Year Change | -87.07% |
| Change since IPO | -93.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| FZMD | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -3.8% | -2.3% | 0.7% |
| 1Y | n/a | -0.01% | 23.9% |
Return vs Industry: Insufficient data to determine how FZMD performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how FZMD performed against the US Market.
Price Volatility
| FZMD volatility | |
|---|---|
| FZMD Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FZMD's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine FZMD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Chris Reeg | www.fusemedical.com |
Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues.
Fuse Medical, Inc. Fundamentals Summary
| FZMD fundamental statistics | |
|---|---|
| Market cap | US$6.68m |
| Earnings (TTM) | US$3.98m |
| Revenue (TTM) | US$18.40m |
1.7x
P/E Ratio0.4x
P/S RatioIs FZMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FZMD income statement (TTM) | |
|---|---|
| Revenue | US$18.40m |
| Cost of Revenue | US$6.03m |
| Gross Profit | US$12.38m |
| Other Expenses | US$8.40m |
| Earnings | US$3.98m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.057 |
| Gross Margin | 67.25% |
| Net Profit Margin | 21.61% |
| Debt/Equity Ratio | -958.8% |
How did FZMD perform over the long term?
See historical performance and comparison